Mineralys Therapeutics Inc MLYS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:15 PM EDT
12.97quote price arrow up+0.17 (+1.33%)
Volume
30,044
52 week range
5.85 - 17.70
Loading...
  • Open13.09
  • Day High13.09
  • Day Low12.73
  • Prev Close12.80
  • 52 Week High17.70
  • 52 Week High Date05/10/23
  • 52 Week Low5.85
  • 52 Week Low Date11/22/23

Key Stats

  • Market Cap643.716M
  • Shares Out49.63M
  • 10 Day Average Volume0.15M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change50.58

KEY STATS

  • Open13.09
  • Day High13.09
  • Day Low12.73
  • Prev Close12.80
  • 52 Week High17.70
  • 52 Week High Date05/10/23
  • 52 Week Low5.85
  • 52 Week Low Date11/22/23
  • Market Cap643.716M
  • Shares Out49.63M
  • 10 Day Average Volume0.15M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change50.58

RATIOS/PROFITABILITY

  • EPS (TTM)-1.79
  • P/E (TTM)-7.24
  • Fwd P/E (NTM)-4.96
  • EBITDA (TTM)-84.657M
  • ROE (TTM)-76.13%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/15/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Mineralys Therapeutics Inc

 

Profile

MORE
Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing medicines to target hypertension, chronic kidney disease (CKD) and other diseases driven by abnormally elevated aldosterone. The Company’s product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor (ASI) that the Company is initially developing for the treatment of patients with uncontrolled hypertension...
Brian Slingsby M.D., Ph.D.
Executive Chairman of the Board, Founder
Jon Congleton
Chief Executive Officer, Director
Adam Levy
Chief Financial Officer, Company Secretary
Address
150 N. Radnor Chester Road, Suite F200
Radnor, PA
19087
United States

Top Peers

SYMBOLLASTCHG%CHG
KRRO
Korro Bio Inc
61.00+0.01+0.02%
PHAT
Phathom Pharmaceuticals Inc
9.54+0.29+3.08%
COGT
Cogent Biosciences Inc
7.28+0.35+5.05%
SVRA
Savara Inc
4.65-0.30-6.06%
OLMA
Olema Pharmaceuticals Inc
10.20-0.20-1.92%